Anti-SHH / Sonic Hedgehog, clone ABE-19

Rabbit IgG in phosphate buffered saline, pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol, 0.4-0.5mg/ml BSA. Sonic Hedgehog antibody targets Sonic Hedgehog (SHH), a secreted signaling protein that functions as a key morphogen controlling embryonic development and tissue patterning. SHH is synthesized as a precursor protein that undergoes autocatalytic processing to generate an active N-terminal signaling fragment, which is subsequently modified by lipid attachment to regulate its distribution and signaling range. SHH is secreted into the extracellular space, where it establishes concentration gradients that direct cell fate specification, proliferation, and differentiation in developing tissues. This antibody is a recombinant rabbit monoclonal, providing defined specificity and consistent performance for research applications.Functionally, SHH signaling operates through the Hedgehog pathway, in which SHH binding to the Patched receptor relieves inhibition of Smoothened, leading to activation of downstream transcriptional programs mediated by GLI transcription factors. This pathway is essential for patterning of the neural tube, limb development, and organogenesis, as well as for regulation of stem and progenitor cell populations. SHH expression and signaling intensity must be tightly controlled to ensure proper spatial and temporal developmental outcomes. A Sonic Hedgehog antibody supports studies examining developmental signaling and morphogen-driven regulation.Beyond embryogenesis, SHH continues to play roles in tissue maintenance, repair, and regeneration in adult organisms. Aberrant reactivation or dysregulation of SHH signaling is associated with pathological conditions characterized by altered cell proliferation and differentiation. Analysis of SHH expression provides insight into pathway activation states and the biological processes governed by Hedgehog signaling.From a biological and disease-relevance perspective, SHH has been extensively studied in developmental disorders and cancer biology. Constitutive or inappropriate activation of Hedgehog signaling contributes to tumorigenesis in multiple tissues. As a central ligand in this pathway, SHH is frequently examined in studies investigating signaling regulation, disease mechanisms, and pathway modulation.At the molecular level, SHH is encoded by the SHH gene and produces a precursor protein that is proteolytically processed to yield the active signaling domain. Regulation of SHH activity depends on controlled expression, processing, secretion, and interaction with pathway receptors. A Sonic Hedgehog antibody supports research applications focused on developmental biology, signal transduction, and pathway analysis, with NSJ Bioreagents providing reagents intended for research use.